Compare Piramal Healthcare with Divis Laboratories - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs DIVIS LABORATORIES - Comparison Results

PIRAMAL ENTERPRISES     Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PIRAMAL ENTERPRISES DIVIS LABORATORIES PIRAMAL ENTERPRISES/
DIVIS LABORATORIES
 
P/E (TTM) x 17.4 34.9 49.8% View Chart
P/BV x 1.1 6.7 16.5% View Chart
Dividend Yield % 1.6 0.9 176.0%  

Financials

 PIRAMAL ENTERPRISES   DIVIS LABORATORIES
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-19
DIVIS LABORATORIES
Mar-19
PIRAMAL ENTERPRISES/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs3,3031,639 201.5%   
Low Rs1,7971,115 161.1%   
Sales per share (Unadj.) Rs716.5186.3 384.5%  
Earnings per share (Unadj.) Rs79.751.0 156.4%  
Cash flow per share (Unadj.) Rs107.957.3 188.3%  
Dividends per share (Unadj.) Rs28.0016.00 175.0%  
Dividend yield (eoy) %1.11.2 94.5%  
Book value per share (Unadj.) Rs1,477.5261.8 564.4%  
Shares outstanding (eoy) m184.45265.47 69.5%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x3.67.4 48.1%   
Avg P/E ratio x32.027.0 118.4%  
P/CF ratio (eoy) x23.624.0 98.3%  
Price / Book Value ratio x1.75.3 32.8%  
Dividend payout %35.131.4 111.9%   
Avg Mkt Cap Rs m470,292365,592 128.6%   
No. of employees `0007.811.8 66.0%   
Total wages/salary Rs m22,5045,423 415.0%   
Avg. sales/employee Rs Th16,899.44,175.1 404.8%   
Avg. wages/employee Rs Th2,877.7457.7 628.7%   
Avg. net profit/employee Rs Th1,879.91,141.8 164.6%   
INCOME DATA
Net Sales Rs m132,15349,463 267.2%  
Other income Rs m3,1281,556 201.0%   
Total revenues Rs m135,28151,019 265.2%   
Gross profit Rs m66,29018,718 354.1%  
Depreciation Rs m5,2021,689 308.0%   
Interest Rs m44,09735 125,992.6%   
Profit before tax Rs m20,11918,551 108.5%   
Minority Interest Rs m3,1940-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m8,6115,023 171.4%   
Profit after tax Rs m14,70113,527 108.7%  
Gross profit margin %50.237.8 132.5%  
Effective tax rate %42.827.1 158.1%   
Net profit margin %11.127.3 40.7%  
BALANCE SHEET DATA
Current assets Rs m122,74246,501 264.0%   
Current liabilities Rs m310,8108,468 3,670.6%   
Net working cap to sales %-142.376.9 -185.1%  
Current ratio x0.45.5 7.2%  
Inventory Days Days23131 17.6%  
Debtors Days Days3986 45.2%  
Net fixed assets Rs m116,90425,797 453.2%   
Share capital Rs m369531 69.5%   
"Free" reserves Rs m272,16168,962 394.7%   
Net worth Rs m272,53069,493 392.2%   
Long term debt Rs m270,1960-   
Total assets Rs m856,26180,383 1,065.2%  
Interest coverage x1.5531.0 0.3%   
Debt to equity ratio x1.00-  
Sales to assets ratio x0.20.6 25.1%   
Return on assets %6.916.9 40.7%  
Return on equity %5.419.5 27.7%  
Return on capital %12.426.7 46.4%  
Exports to sales %00-   
Imports to sales %024.6 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA12,187 0.0%   
Fx inflow Rs m15,20041,238 36.9%   
Fx outflow Rs m4,88912,405 39.4%   
Net fx Rs m10,31228,833 35.8%   
CASH FLOW
From Operations Rs m-115,9759,543 -1,215.3%  
From Investments Rs m-8,265-6,854 120.6%  
From Financial Activity Rs m107,525-2,459 -4,372.0%  
Net Cashflow Rs m-16,650230 -7,251.8%  

Share Holding

Indian Promoters % 52.9 52.0 101.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.0 11.8 33.9%  
FIIs % 26.6 19.0 140.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 16.5 17.2 95.9%  
Shareholders   93,274 31,796 293.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PIRAMAL ENTERPRISES With:   SANOFI INDIA  ABBOTT INDIA  PLETHICO PHARMA  WYETH LTD  TORRENT PHARMA  

Compare PIRAMAL ENTERPRISES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Strong; HCL Tech and Tech Mahindra Top Gainers(09:30 am)

Asian share markets are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 0.6% while the Hang Seng is up 0.4%.

Related Views on News

DIVIS LABORATORIES 2018-19 Annual Report Analysis (Annual Result Update)

Oct 10, 2019 | Updated on Oct 10, 2019

Here's an analysis of the annual report of DIVIS LABORATORIES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

DIVIS LABORATORIES Announces Quarterly Results (1QFY20); Net Profit Up 0.4% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 0.4% YoY). Sales on the other hand came in at Rs 11 bn (up 14.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY20); Net Profit Up 390.0% (Quarterly Result Update)

Aug 1, 2019 | Updated on Aug 1, 2019

For the quarter ended June 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 4 bn (up 390.0% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 9, 2019 | Updated on Jul 9, 2019

Here's an analysis of the annual report of PIRAMAL ENTERPRISES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of PIRAMAL ENTERPRISES. Also includes updates on the valuation of PIRAMAL ENTERPRISES.

DIVIS LABORATORIES Announces Quarterly Results (4QFY19); Net Profit Up 10.6% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 10.6% YoY). Sales on the other hand came in at Rs 13 bn (up 15.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

My Top 10 Stocks for Accelerated Profits

Oct 18, 2019

Equitymaster's co-head of research and editor of Microcap Millionaires, Rahul Shah, talks to us about his market-beating system and his 10 best stocks to buy now. Listen in...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Oct 24, 2019 10:09 AM

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES 5-YR ANALYSIS

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS